73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Exploring better care for pregnant women with precancerous cervical cancer

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002
Study points to new drug target in fight against cancer

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules
Study provides insight on targeted therapies for colorectal cancer metastasis

Study provides insight on targeted therapies for colorectal cancer metastasis

by Allison Perry,University of KentuckyKiller T cells surround a cancer cell. Credit: NIHA new study by University of Kentucky Markey Cancer Center researchers provides new insight on targeted t

Study provides insight on targeted therapies for colorectal cancer metastasis

by Allison Perry,University of KentuckyKiller T cells surround a cancer cell. Credit: NIHA new study by University of Kentucky Markey Cancer Center researchers provides new insight on targeted t
Study reveals insights into how cancer cells evade treatment

Study reveals insights into how cancer cells evade treatment

by Addison Dehaven,South Dakota State UniversityCancers use sugar residues to engage in multidrug resistance. The research conducted by the RAWC Lab reveals breakthrough insights into exactly ho

Study reveals insights into how cancer cells evade treatment

by Addison Dehaven,South Dakota State UniversityCancers use sugar residues to engage in multidrug resistance. The research conducted by the RAWC Lab reveals breakthrough insights into exactly ho
Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers
Designing an emergency stop switch for immunotherapies

Designing an emergency stop switch for immunotherapies

by Ecole Polytechnique Federale de LausanneA mollecule allows for 'switching off' the therapy when a cancer patient's life is in danger. Credit: EPFLImmunotherapy, unlike chemotherapy

Designing an emergency stop switch for immunotherapies

by Ecole Polytechnique Federale de LausanneA mollecule allows for 'switching off' the therapy when a cancer patient's life is in danger. Credit: EPFLImmunotherapy, unlike chemotherapy
Blood cancer discovery identifies high-risk patients, could improve outcomes

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl
Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
Editorial: Genotype matters—tailored screening for germline CHEK2 variants

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var
Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Induced pluripotent stem cells could serve as cancer vaccine, researchers say

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become
Oncology therapy at the end-of-life: Have we missed the mark?

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and